Michael Parker, MD, Ravi Alapati, MD and Ashutosh Kaul, MD One technical challenge regarding NOTES involves the need for adequate closure of the visceral surface being crossed when entering the ...

To date, the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS) 3 is the only prospective randomized study comparing best medical therapy with endovascular stenting for patients ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

The Company revises its guidance expectations for adjusted operating expenses 1,3 for full year 2024 to approximately $104.0 ...

This topic was extensively reviewed recently by Honori and colleagues. [12] Percutaneous transluminal coronary angioplasty and stent placement are becoming an increasingly common and effective ...

In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...

The 2-year results from the LIFE-BTK randomized controlled trial highlighted the sustained benefits of the Esprit below-the-kne ...

The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.

READ ALSO: How To Keep A Check On Your Cholesterol Levels? Procedural Options: In severe cases where blockages significantly impede blood flow, procedures like Percutaneous Transluminal Coronary ...

Sight Sciences also announced that Sam Park, its Chief Operating Officer, who oversaw both R&D and Operations, will be retiring from his role at the Company effective November 15, 2024, and will ...